Patents for C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725) |
---|
03/31/2005 | CA2521811A1 Haloalkyl containing compounds as cysteine protease inhibitors |
03/29/2005 | US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents |
03/24/2005 | WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor |
03/24/2005 | WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
03/24/2005 | US20050065139 Antidiabetic agents; controlling carbohydrate metabolism |
03/23/2005 | EP1515951A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
03/23/2005 | CN1599735A Multi-functional thioxanthone photoinitiators |
03/17/2005 | US20050059729 Substituted cyclic compounds |
03/16/2005 | CN1596251A Piperazine derivatives having SST1 antagonistic activity |
03/16/2005 | CN1594370A Thioxanthone photoinitiator containing aid initiator amino group and preparation method therefor |
03/16/2005 | CN1193000C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same |
03/10/2005 | US20050054690 Phenacyl 2-hydroxy-3-diaminoalkanes |
03/10/2005 | US20050054536 Reacting an cyanoacrylate compound with amidine compound |
03/10/2005 | US20050054018 Using cell cycle checkpoint activation modulators to prevent and treat cell proliferative disorders |
03/08/2005 | US6864397 E.g., 1-(4-(4-pentylcyclohexyl)cyclohexyldifluoromethoxy)-4 -trifluoromethoxybenzene; preparation from difluorocyclo-hexylidenes, e.g. 1-(4-(trans-4-propylcyclohexyl)cyclohexyl-difluoromethoxy)-3,4,5 -trifluorobenzene; liquid crystals |
03/03/2005 | WO2005019159A1 OPTICALLY ACTIVE α-AMINOOXYKETONE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF |
03/03/2005 | US20050049252 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors |
03/03/2005 | US20050049238 Heterocyclic retinoid compounds |
03/02/2005 | EP1510515A1 Phenylglycine derivatives as serine protease inhibitors |
03/02/2005 | EP1509495A1 Anilino liver x-receptor modulators |
03/02/2005 | EP0991636B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
03/02/2005 | CN1191232C Aminomethylcarboxylic acid derivatives |
02/24/2005 | WO2005017185A2 HEPATOCYTE NUCLEAR FACTOR 4α MODULATOR COMPOUNDS |
02/23/2005 | EP1119350B1 Rar antagonists as male anti-fertility agents |
02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
02/17/2005 | WO2005014559A1 Amide derivatives |
02/16/2005 | EP1506959A2 Derivatised molecules for mass spectrometry |
02/15/2005 | US6855832 O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
02/10/2005 | WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor |
02/10/2005 | WO2004093856A3 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
02/10/2005 | US20050032860 CBI analogs of CC-1065 and the duocarmycins |
02/10/2005 | US20050032855 Tetrahydro-2H-thiopyran-4-carboxamide derivative |
02/10/2005 | US20050032848 Administering enzyme inhibitors of beta secretase, an enzyme responsible for the production of amyloid beta peptide by mediating the cleavage of amyloid precursor proteins; Alzheimer's disease; cognition activators; Down's syndrome; neurodegenerative diseases; other dementias of mixed origins |
02/10/2005 | US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
02/10/2005 | US20050032772 Compounds useful as reversible inhibitors of cysteine proteases |
02/09/2005 | CN1578776A Heterocyclic retinoid compounds |
02/03/2005 | WO2005009983A1 Method for the detection of nucleophilic chemical species |
02/03/2005 | WO2004094384A3 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease |
02/03/2005 | US20050026876 9-aminomethyl substituted minocycline compounds |
02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors |
02/02/2005 | CN1575279A Substituted thioacetamides |
02/01/2005 | US6849658 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them |
02/01/2005 | US6849384 Photoacid generators, photoresist compositions containing the same and pattering method with the use of the compositions |
01/27/2005 | US20050020684 Modulators of peroxisome proliferator activated receptors |
01/26/2005 | EP1500643A1 Benzamide derivatives |
01/26/2005 | CN1569812A Aromatic tetramine monomer and aromatic tetramine chydrochloride and their preparation process |
01/25/2005 | US6846843 β-thioamino acids |
01/20/2005 | US20050014860 Nonmigrating; energy curable packaging varnishes, lacquers, printing inks; food applications |
01/19/2005 | EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
01/19/2005 | CN1185223C Novel Compounds and methods for synthesis and therapy |
01/13/2005 | WO2005003125A1 Process for the preparation of 4,4-dimethyl-6-ethynylthiochroman |
01/13/2005 | US20050010050 Antiinflammatory agents; antiarthritic agents; anticancer agents; analgesics |
01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
01/13/2005 | US20050009820 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
01/12/2005 | EP1299373B1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
01/12/2005 | EP1171423B1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
01/12/2005 | CN1184200C Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same |
01/06/2005 | WO2005000233A2 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |
01/06/2005 | US20050004373 preparation of intermediates for tazarotene using a Vilsmeier Haack reaction. |
01/06/2005 | US20050004203 NAALADase inhibitors; effecting transforming growth factor beta or neuronal activity |
01/06/2005 | CA2530581A1 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |
01/05/2005 | CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
12/30/2004 | US20040266857 11,12-dehydro-naphtho[1,2-b]thioxane-9,10-dione derivatives; antiproliferative agents; psoriasis, cancer |
12/29/2004 | WO2004113289A2 Glycosidase inhibitors and methods of synthesizing same |
12/29/2004 | EP1274456B1 Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies |
12/29/2004 | EP0874626B1 Use of inhibitors of retinoic acid activity for wound healing |
12/29/2004 | CA2534094A1 Glycosidase inhibitors and methods of synthesizing same |
12/23/2004 | WO2004111028A1 Cyclic onium compounds and glucosidase inhibitors |
12/16/2004 | WO2004108661A1 Amidino compounds as cysteine protease inhibitors |
12/16/2004 | WO2004087686A3 Benzopyran compounds useful for treating inflammatory conditions |
12/16/2004 | US20040254327 Bisphenol a derivatives containing one biaryl group and a spacer; monomers for polycarbonates |
12/16/2004 | US20040253730 Identifying modulators which induce apoptosis and activate cell cycle checkpoint systems; for use in treatment and prevention of cell proliferative disorders |
12/16/2004 | US20040253216 Activated checkpoint therapy and methods of use thereof |
12/16/2004 | CA2526694A1 Amidino compounds as cysteine protease inhibitors |
12/15/2004 | CN1554651A Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
12/15/2004 | CN1179958C Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
12/08/2004 | EP0966420B1 2-arylcyclopentane-1,3-diones |
12/08/2004 | CN1178902C New O-acyloxime photointiators |
12/08/2004 | CN1178651C Lyophilized thioxanthenone anti-tumor agents |
12/07/2004 | US6827876 Using alpha, alpha -difluorocyclohexylidene derivative as starting material to obtain difluoromethyl ether derivative |
12/02/2004 | WO2004104051A1 Bimolecular photoinitiator systems |
12/02/2004 | WO2004072031A3 Phenylacetamides and their use as glucokinase modulators |
12/02/2004 | US20040242901 Sulfoniun salts, methods for their preparation and use thereof as phtoinitiators for radiation curable systems |
12/01/2004 | EP1481973A1 Heterocycle-bearing onium salts |
12/01/2004 | EP1481970A1 Novel herbicides |
12/01/2004 | EP1480968A1 Thioxanthone derivatives, and their use as cationic photoinitiators |
12/01/2004 | EP1480967A1 Novel fused ring compounds, and their use as cationic photoinitiators |
12/01/2004 | EP1480944A2 Substituted aryl ketones |
12/01/2004 | CN1177821C Matrix metalloprotease inhibitors |
11/30/2004 | US6825360 Bicyclic aromatic compounds |
11/30/2004 | US6825354 Osteoporosis; rheumatic diseases |
11/25/2004 | US20040235885 Novel composition and method for stabilizing the same |
11/25/2004 | US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
11/23/2004 | US6822102 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of COX-2 mediated disorders |
11/23/2004 | CA2105503C Carboxanilides, their preparation and compositions containing them for controlling harmful fungi |
11/17/2004 | EP1274700B1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders |
11/17/2004 | EP1210333B1 p-Tolyl-heterocycles as herbicides |
11/16/2004 | US6818666 Bi-aromatic compounds linked via a heteroethylene radical, and pharmaceutical and cosmetic compositions using them |